Position in RYTM
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$280,350
New position
Shares Held
2,525
first reported quarter
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#215
of 299 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Nykredit A/S holds $205,297,788 across 106 Biotechnology names. RYTM ranks #22 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
248,068 | $123,222,817 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
41,782 | $26,052,748 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
51,208 | $15,415,144 | |
| 4 | INSM |
INSMED Inc
|
103,144 | $10,997,213 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
52,663 | $9,862,726 | |
| 6 | INCY |
Incyte Corp
|
48,015 | $5,442,980 | |
| 7 | ONC |
BeOne Medicines Ltd.
|
4,225 | $1,203,998 | |
| 8 | MRNA |
Moderna, Inc.
|
13,042 | $913,331 |
All Filings in RYTM
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $280,350 | 2,525 | Shares | Defined | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||